Swiss pharma company set for major US investment

 

By JULIAN SHEA in London | China Daily Global | Updated: 2025-04-23 09:34

Roche tablets are seen positioned in front of a displayed Roche logo in this photo illustration shot in Zenica, Bosnia and Herzegovina, Jan 22, 2016. [Photo/Agencies]

Swiss pharmaceutical group Roche has become the latest big company to make a major investment decision since the announcement of the United States government's tariffs program, after it revealed that over the next five years it will invest $50 billion in the US, where it currently employs 25,000 people, resulting in the creation of more than 12,000 new jobs.

Around 1,000 of these jobs will be within the company with the others in supporting roles, including construction.

The decision follows in the wake of another Swiss company, Novartis, saying that it would invest $23 billion in the US. Sector rivals Johnson& Johnson and Eli Lilly have also made significant recent announcements.

List
 First 1 Last